DK1384717T3 - 2-(2'Triphenylmethyl-2'H-tetrazol-5'-yl)phenylboronsyre som mellemprodukter til syntese af AII receptorantagonister - Google Patents

2-(2'Triphenylmethyl-2'H-tetrazol-5'-yl)phenylboronsyre som mellemprodukter til syntese af AII receptorantagonister

Info

Publication number
DK1384717T3
DK1384717T3 DK03018662T DK03018662T DK1384717T3 DK 1384717 T3 DK1384717 T3 DK 1384717T3 DK 03018662 T DK03018662 T DK 03018662T DK 03018662 T DK03018662 T DK 03018662T DK 1384717 T3 DK1384717 T3 DK 1384717T3
Authority
DK
Denmark
Prior art keywords
triphenylmethyl
tetrazol
intermediates
synthesis
receptor antagonists
Prior art date
Application number
DK03018662T
Other languages
English (en)
Inventor
Young Sek Lo
Lucius Thomas Rossano
Robert D Larsen
Anthony O King
Original Assignee
Du Pont
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/793,514 external-priority patent/US5130439A/en
Priority claimed from US07/911,812 external-priority patent/US5310928A/en
Application filed by Du Pont, Merck & Co Inc filed Critical Du Pont
Priority claimed from PCT/US1992/009979 external-priority patent/WO1993010106A1/en
Application granted granted Critical
Publication of DK1384717T3 publication Critical patent/DK1384717T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/05Cyclic compounds having at least one ring containing boron but no carbon in the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03018662T 1991-11-18 1992-11-18 2-(2'Triphenylmethyl-2'H-tetrazol-5'-yl)phenylboronsyre som mellemprodukter til syntese af AII receptorantagonister DK1384717T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/793,514 US5130439A (en) 1991-11-18 1991-11-18 Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
US07/911,813 US5206374A (en) 1991-11-18 1992-07-10 Process for preparing tetrazolylphenylboronic acid intermediates
US07/911,812 US5310928A (en) 1991-11-18 1992-07-10 Process for preparing biphenyltetrazole compounds
PCT/US1992/009979 WO1993010106A1 (en) 1991-11-18 1992-11-18 Tetrazolylphenylboronic acid intermediates for the synthesis of aii receptor antagonists

Publications (1)

Publication Number Publication Date
DK1384717T3 true DK1384717T3 (da) 2008-09-08

Family

ID=27121398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03018662T DK1384717T3 (da) 1991-11-18 1992-11-18 2-(2'Triphenylmethyl-2'H-tetrazol-5'-yl)phenylboronsyre som mellemprodukter til syntese af AII receptorantagonister

Country Status (3)

Country Link
US (1) US5206374A (da)
DK (1) DK1384717T3 (da)
ES (1) ES2306829T3 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4319041A1 (de) * 1992-10-23 1994-04-28 Bayer Ag Trisubstituierte Biphenyle
CA2179067A1 (en) * 1993-12-23 1995-06-29 Gordon Creston Campbell, Jr. Polymorphs of losartan and the process for the preparation of form ii of losartan
CN1101393C (zh) * 1996-10-29 2003-02-12 麦克公司 芦沙坦的结晶方法
HU222773B1 (hu) * 2000-04-21 2003-10-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás egy ismert tetrazolszármazék előállítására
EP1458693A4 (en) * 2001-11-14 2005-02-09 Teva Pharma Amorphous and crystalline forms of losartan potassium and method for making same
CA2482857A1 (en) * 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
GB0402262D0 (en) * 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
US20070026026A1 (en) * 2005-08-01 2007-02-01 David Delmarre Oral liquid losartan compositions
WO2008058402A1 (en) 2006-11-17 2008-05-22 Queen's University At Kingston Compounds and methods for treating protein folding disorders
CN101475564B (zh) * 2009-01-22 2012-05-23 江苏德峰药业有限公司 一种氯沙坦钾的制备方法
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
CN108047208B (zh) * 2018-01-12 2022-03-22 浙江华海药业股份有限公司 一种降低氯沙坦二聚物杂质的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH530980A (de) * 1969-03-05 1972-11-30 Sandoz Ag Verfahren zur Herstellung von Imidazo(2,1-a)isoindolen
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5039814A (en) * 1990-05-02 1991-08-13 Merck & Co., Inc. Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl)benzenes
GB9017480D0 (en) * 1990-08-09 1990-09-26 Ici Plc Chemical process
GB9017482D0 (en) * 1990-08-09 1990-09-26 Ici Plc Manufacturing process

Also Published As

Publication number Publication date
US5206374A (en) 1993-04-27
ES2306829T3 (es) 2008-11-16

Similar Documents

Publication Publication Date Title
DK0969835T3 (da) Anvendelse af centrale cannabinoidreceptorantagonister til regulering af velsmag
DK0657428T3 (da) Fremstilling af 3,4,4-trisubstituerede-piperidinyl-N-alkylcarboxylater og mellemprodukter, der er egnede som opioidantagonister
DE69207351D1 (de) Fibrinogen-Rezeptor-Antagoniste
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
DK0893434T3 (da) Mellemprodukter til fremstilling af oximethere
DK158262C (da) Mellemprodukter til fremstilling af herbicide tetrahydrophthalimidforbindelser
MX9101311A (es) Antagonistas receptores de fibrinogeno
NO943348D0 (no) Kondenserte indolderivater som 5HT4-reseptorantagonister
DK1384717T3 (da) 2-(2'Triphenylmethyl-2'H-tetrazol-5'-yl)phenylboronsyre som mellemprodukter til syntese af AII receptorantagonister
DK0455510T3 (da) Anvendelse af 5HT1A-receptoragonist til inhibering af mavesyresekretion
DK0991640T3 (da) Syntese af mellemprodukter, der er anvendelige til fremstilling af bromsubstituerede tricykliske forbindelser
DE69425655T2 (de) Antagonisten des fibrinogenrezeptors
FI930191A (fi) Inhibering av bindning av mac-1-receptorn till fibrinogen med anvaendning av d -homologer
BG99863A (en) Antagonists of fibrogenous receptor
DK204887A (da) Aggregat til afkastning af fjerkraekroppe
DK0558139T3 (da) Fremgangsmåde til fremstilling af fibrinogenreceptorantagonister
DK665489D0 (da) Fremgangsmaade til fremstilling af mono-n-alkylerede polyazamakrocykliske forbindelser
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
FI943934A (fi) Menetelmä fibrinogeenireseptoriantagonisteina käyttökelpoisten 0-(4-(4-piperdinyyli)butyyli)tyrosiinijohdannaisten valmistamiseksi
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
FI943359A (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
DK0662961T3 (da) Fremgangsmåde til syntese af nyttige mellemprodukter af substituerede imidazolforbindelser
DK0428039T3 (da) Fremgangsmåde til fremstilling af højfluorerede alkylbromider
ID17938A (id) Penghambatan metalloproreinase-metalloproteinase oleh asam-asam 2-(w-aroilalkil)-4-biaril-4-oksobutirat
FR2764601B1 (fr) Procede de preparation de composes de type 4-(alkyl)-3- alcoxy-anilines